Click on image to view larger version.

Figure 4 Thirty-day death, reinfarction, and recurrent angina in patients 75 years of age and in those >75 years of age treated with full-dose tenecteplase and enoxaparin (Enox) and half-dose teneteplase and full-dose abciximab (Abc) compared with those treated with full-dose abciximab and weight-adjusted unfractionated heparin (UFH).